The Parkinson's Institute
Sunnyvale, California, United States
Medical clinic in Mountain View, California
2500 Hospital Dr building 10 suite 1, Mountain View, CA 94040
About The Parkinson's Institute
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at The Parkinson's Institute
During the past decade, The Parkinson's Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
2012-06-12
2023-06-30
Active, not recruiting
1,194
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
2013-04-01
2030-01-01
Active, not recruiting
1,900
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
2013-12-02
2034-02-05
Active, not recruiting
1,087
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
2014-03-29
2028-10-28
Active, not recruiting
608
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
2014-06-16
2022-04-15
Completed
1,864
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
2014-08-18
2026-10-10
Active, not recruiting
450
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
2014-07-22
2023-12-31
Active, not recruiting
280
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Parkinson's Institute" #1 sponsor was "Impax Laboratories, LLC" with 3 trials, followed by "Newron Pharmaceuticals SPA" with 3 trials
sponsored, "The Parkinson's Institute" with 3 trials sponsored, "Chelsea Therapeutics" with 2 trials sponsored and "The Parkinson Study Group"
with 2 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 18 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Parkinson's Institute"
#1 collaborator was "H. Lundbeck A/S" with 2 trials as a collaborator, "Michael J. Fox Foundation for Parkinson's Research" with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "Bausch Health Americas, Inc." with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were
collaborators in the rest 20 trials.
Clinical Trials Conditions at The Parkinson's Institute
According to Clinical.Site data, the most researched conditions in "The Parkinson's Institute" are
"Parkinson's Disease" (14 trials), "Parkinson Disease" (4 trials), "Dopamine Beta Hydroxylase Deficiency" (2 trials), "Idiopathic Parkinson's Disease" (2 trials) and "Essential Tremor" (1 trials). Many other conditions were trialed in "The Parkinson's Institute" in a lesser frequency.
Clinical Trials Intervention Types at The Parkinson's Institute
Most popular intervention types in "The Parkinson's Institute" are "Drug" (19 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Droxidopa" (2 trials), "2 mg perampanel" (1 trials), "4 mg perampanel" (1 trials) and "AFQ056 with L-dopa" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Parkinson's Institute
The vast majority of trials in "The Parkinson's Institute" are
25 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at The Parkinson's Institute
Currently, there are NaN active trials in "The Parkinson's Institute".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 19 completed trials in The Parkinson's Institute,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in The Parkinson's Institute, 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 2 trials that are defined as “Not Applicable".